We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

94 hedge funds and large institutions have $287M invested in Rigel Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 94 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

86% less call options, than puts

Call options by funds: $399K | Put options by funds: $2.79M

Holders
94
Holders Change
+94
Holders Change %
–
% of All Funds
3.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
94
Increased
–
Reduced
–
Closed
–
Calls
$399K
Puts
$2.79M
Net Calls
-$2.39M
Net Calls Change
-$2.39M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
U
76
UBS
Switzerland
$73K +$100K +2,213 New
FSA
77
Franklin Street Advisors
North Carolina
$71K +$97.4K +2,150 New
OC
78
Oppenheimer & Co
New York
$69K +$93.8K +2,070 New
ST
79
Spot Trading
Illinois
$61K +$83.3K +1,838 New
BJ
80
BlackRock Japan
Japan
$58K +$78K +1,722 New
Invesco
81
Invesco
Georgia
$54K +$73.2K +1,615 New
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$47K +$63.8K +1,408 New
Nomura Holdings
83
Nomura Holdings
Japan
$39K +$52.7K +1,162 New
HighTower Advisors
84
HighTower Advisors
Illinois
$33K +$45.3K +1,000 New
Teacher Retirement System of Texas
85
Teacher Retirement System of Texas
Texas
$20K +$26.9K +593 New
Ameriprise
86
Ameriprise
Minnesota
$18K +$24.6K +543 New
ILIM
87
Irish Life Investment Managers
Ireland
$14.8K +$20.2K +445 New
BlackRock
88
BlackRock
New York
$11K +$15K +330 New
WAM
89
Wolverine Asset Management
Illinois
$9K +$12.2K +270 New
TRCT
90
Tower Research Capital (TRC)
New York
$7K +$9.15K +202 New
NTCOC
91
Northern Trust Company of Connecticut
Connecticut
$5K +$6.89K +152 New
Wells Fargo
92
Wells Fargo
California
$5K +$7.25K +160 New
LWCFA
93
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– +$136 +3 New
CGT
94
Capital Guardian Trust
California
– +$227 +5 New
1 2 3
4

RIGL Hedge Fund Activity: Q2 2013 in Review

94 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q2 2013, worth a combined $287M.

Buyers outnumbered sellers: 94 funds opened new RIGL positions and 0 closed out — a net gain of 94 holders — while 0 added to existing stakes and 0 trimmed.

  • 94 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $287M of Rigel Pharmaceuticals stock for Q2 2013.
  • 94 funds opened new Rigel Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +94 holders.

Based on aggregated 13F filings for Q2 2013.